Moreover, Tetsu et al. (9) determined that inhibition of CDK2 and CDK4 leads to G1 arrest in CRC following inhibition of the mitogen-activated protein (MAP) kinase pathways, which highlights the relationships between the CDKs and MAP kinases. This evidence concerns the gene CDK2 and colorectal carcinoma.